Basiliximab is a monoclonal antibody that targets and blocks the activation of interleukin-2 receptors on the surface of activated T lymphocytes. By blocking this activation, basiliximab inhibits the proliferation of T lymphocytes and reduces the risk of acute rejection in organ transplant patients.

Used in case of Prophylaxis of acute transplant rejection in patients receiving renal transplant.

The recommended dose is 20 mg as a single intravenous injection within 2 hours before transplantation and 4 days after transplantation
The injection should be administered slowly over 20 to 30 minutes.
Doses may be changed in special conditions so always follow your doctor's or pharmacist's instructions.
If you take more than you should, talk to a doctor or go to the hospital straight away.
If you forget to take a dose, take it as soon as you remember it unless it is nearly time for your next dose.
Do not take a double dose (two doses at the same time) to make up for the forgotten dose.

Like all medicines, this medicine can cause side effects, although not everybody gets them, but you may suffer from:

If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Your doctor will discuss the possible risks and benefits of using this medicine during pregnancy and breast-feeding

This drug should be administered under the supervision of a healthcare professional.
It may increase the risk of infections; monitor for signs of infection.
Regular monitoring of kidney function is advised.

Store in a refrigerator between 2°C to 8°C (36°F to 46°F)
Protect from light
Do not freeze.
Keep this medicine out of the sight and reach of children.
Store in the original package to protect it from moisture.
Do not use this medicine after the expiry date which is stated on the box/blisters/label. The expiry date refers to the last day of the month.

Simulect

1 result for Simulect